0 Yorumlar
0 hisse senetleri
944 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Precision and Power: How SGLT2 Inhibitors and Cardiac Drug Therapies are Personalizing Heart Failure CareThe modern era of cardiology is defined by the pursuit of personalized medicine, where treatments are tailored to the individual patient based on their specific disease characteristics and risk factors. At the forefront of this movement are novel cardiac drug therapies, with SGLT2 inhibitors representing a prime example of this targeted approach. These drugs are not simply new...0 Yorumlar 0 hisse senetleri 20 Views 0 önizleme
-
Volatile Corrosion Inhibitors VCI Packaging Market Driven by Expanding Manufacturing and Export ActivitiesThe Volatile Corrosion Inhibitors VCI Packaging Market is experiencing remarkable growth, with the market size projected to reach $3.132 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.8%. This expansion is driven by heightened demand for corrosion protection solutions across various sectors, particularly in North America and Asia-Pacific. Since VCI packaging serves as a...0 Yorumlar 0 hisse senetleri 402 Views 0 önizleme
-
What Are the Latest Innovations in Cell Cycle Inhibitors Market for Cancer Therapy?Cell Cycle Inhibitors Market Summary: According to the latest report published by Data Bridge Market Research, the Cell Cycle Inhibitors Market CAGR Value Cell Cycle Inhibitors Market report, businesses can acquire details about market drivers and market restraints which help them to guess about reducing or growing the production of particular product. It also arranges for top...0 Yorumlar 0 hisse senetleri 383 Views 0 önizleme
-
Antihypertensive Drugs Market Expanding with Rising Hypertension PrevalenceAccording to a new report from Intel Market Research, the global Antihypertensive Drugs market was valued at USD 31.96 billion in 2024 and is projected to grow from USD 33.12 billion in 2025 to reach USD 40.62 billion by 2034, exhibiting a CAGR of 3.6% during the forecast period (2025–2034). This steady growth trajectory is underpinned by the escalating global burden of hypertension,...0 Yorumlar 0 hisse senetleri 681 Views 0 önizleme
-
Global Diabetes Drugs Market Growing at 12.1% CAGR Through 2032According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...0 Yorumlar 0 hisse senetleri 187 Views 0 önizleme
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Solid Potassium Sorbate Market Growing at 4.5% CAGR Through 2034According to a new report from Intel Market Research, the global Solid Potassium Sorbate market was valued at USD 280 million in 2024 and is projected to reach USD 420 million by 2034, growing at a robust CAGR of 4.5% during the forecast period (2025–2034). This growth is propelled by increasing demand for processed foods with extended shelf life, stringent food safety regulations...0 Yorumlar 0 hisse senetleri 669 Views 0 önizleme
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek